The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Healthcare integration and regulatory framework address privacy concerns, ensuring genetic data security. Whole genome sequencing, microarray genetic analysis, and targeted analysis provide valuable ...

Clinicians should prioritize genetic testing for young children who show signs of intellectual disability (ID) or developmental delays, according to a new report from the American Academy of ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

As genetic analysis expands to serve everything from population-scale studies to precision-driven clinical decisions, laboratories are under growing pressure to move faster while managing increasingly ...

Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone. DNA and ...

NEW YORK--(BUSINESS WIRE)--Nucleus Genomics, a next-generation consumer genetic testing and analysis company, has raised $14 million in a new funding round led by Alexis Ohanian's Seven Seven Six. The ...